Another important factor in the slow uptake of EMA methods to study change process in AUD treatment research may be a failure to fully appreciate the value of well-conducted EMA studies in improving AUD treatment.
Recently, specific glutamatergic receptors have been identified as potential novel targets for intervention in AUD.
Less is known about the specific role, if any, of CRFBP in AUD.
These results suggest that selective antagonism of the NMDA or AMPA/kainate receptors may be of therapeutic potential in AUD.
In the case of Corg, about 8 % reduction was observed with PUD and PPD storage and less than 1.5%% in AUD and APD.
However, it remains unclear whether: 1) specific latent internalizing psychopathology risk-profiles predict AUD-incidence and 2) specific latent internalizing comorbidity-profiles in AUD predict AUD-stability.
Despite the large and growing public health problem of alcohol use disorders (AUD) in India there is a dearth of evidence about the longitudinal outcomes in AUD.
Increasing trend was also observed with EC, in which maximum increase of 33.5 ± 0.1 and 27.1 ± 2.6 % was in AUD and APD storage and 15.5 ± 1.0 and 6.8 ± 3.4 %, respectively, in PUD and PPD.
Further storage showed a drastic reduction in the ASA activity with all types of storage: 93.3 ± 0.4, 96.8 ± 0.3, 97.9 ± 0.2, and 99.4 ± 0.1%%, in AUD, APD, PUD and PPD, respectively.
The WFPS values increased to the extent of 22.4 ± 3.4 and 32.7 ± 0.5 % in AUD and APD storage and decreased by 18.4 ± 2.0 and 8.5 ± 5.8 % in the PUD and PPD storage, respectively.
The bulk density increased in the PUD and PPD storage to the extent of 49.7 ± 0.8 and 45.8 ± 1.7 % and in AUD and APD to the extent of 21.8 ± 2.0 and 29.1 ± 0.3 %, respectively.
